Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis

Primary sclerosing cholangitis (PSC) is an autoimmune disease of the hepatobiliary system for which effective therapy has not been established. Leukocytapheresis (LCAP) therapy is known to effective in patients with ulcerative colitis (UC). In addition, effects of LCAP therapy were reported on some...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Itou, Minoru, Mitsuyama, Keiichi, Kawaguchi, Takumi, Okabe, Yoshinobu, Suga, Hideya, Masuda, Junya, Yamasaki, Hiroshi, Kuwaki, Kotaro, Taniguchi, Eitaro, Harada, Masaru, Tsuruta, Osamu, Sata, Michio
التنسيق: Artigo
اللغة:Inglês
منشور في: S. Karger AG 2009
الموضوعات:
Published: April 2009
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895181/
https://ncbi.nlm.nih.gov/pubmed/20651970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000210439
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة